GLP-1 tells your pancreas to produce insulin while stopping your body from increasing your blood sugar levels
Notably, a dose-dependent increase in heart rate, peaking at 24 weeks, subsequently decreased [19]
For employers operating on tight benefit budgets, thats an untenable increase to absorb especially when utilization consistently came in higher than projected. In conversations documented by the Kaiser Family Foundation and Peterson Center on Healthcare, employers described trying multiple cost-management strategies step therapy requirements, prior authorization, weight-loss program prerequisites before ultimately concluding that no guardrail was controlling the spend fast enough. Importantly, the law doesnt require employers to offer GLP-1 coverage
Compounding pharmacies in some countries have started producing GLP-1 drugs like semaglutide during shortages
Furthermore, the speed, depth, and reach of these two genres of medicine, are now being dramatically augmented by digitalisation and artificial intelligence (AI)